Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOXEPIN vs IMIPRAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOXEPIN vs IMIPRAMINE: Safety Overview

Metric DOXEPIN IMIPRAMINE
Total FAERS Reports 4,021 1,077
Deaths Reported 1,613 242
Death Rate 40.1% 22.5%
Hospitalizations 1,091 338
Average Patient Age 49.2 yrs 50.3 yrs
% Female Patients 63.8% 59.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Teva Pharmaceuticals USA, Inc. Advanced Rx Pharmacy of Tennessee, LLC
Route TOPICAL ORAL
Marketing Status Discontinued Discontinued